Home/Filings/4/0000950170-25-087534
4//SEC Filing

Duarte Ira 4

Accession 0000950170-25-087534

CIK 0000818033other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 5:53 PM ET

Size

7.0 KB

Accession

0000950170-25-087534

Insider Transaction Report

Form 4
Period: 2025-06-16
Duarte Ira
EVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-16+12,500148,649 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-16+12,50025,000 total
    Exercise: $0.00Common Stock (12,500 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001488864

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:53 PM ET
Size
7.0 KB